{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,7]],"date-time":"2026-11-07T14:38:38Z","timestamp":1794062318353,"version":"4.8.0"},"reference-count":52,"publisher":"American Society of Hematology","issue":"1","content-domain":{"domain":["ashpublications.org"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2020,12,4]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>An estimated 1 million people in the United States have functional or anatomic asplenia or hyposplenia. Infectious complications due to encapsulated organisms such as Streptococcus pneumoniae, Neisseria meningitidis, and Haemophilus influenzae can lead to fulminant sepsis and death, particularly in young children, in the period shortly after splenectomy, and in immunocompromised patients. Patients with asplenia are also at risk for less common infections due to Capnocytophaga, Babesia, and malaria. Antibiotic prophylaxis, vaccines, and patient and family education are the mainstays of prevention in these at-risk patients. Recommendations for antibiotic prophylaxis typically target high-risk periods, such as 1 to 3 years after splenectomy, children \u22645 years of age, or patients with concomitant immunocompromise. However, the risk for sepsis is lifelong, with infections occurring as late as 40 years after splenectomy. Currently available vaccines recommended for patients with asplenia include pneumococcal vaccines (13-valent pneumococcal conjugate vaccine followed by the 23-valent pneumococcal polysaccharide vaccine), meningococcal vaccines (meningococcal conjugate vaccines for serogroups A, C, Y and W-135 and serogroup B meningococcal vaccines), H. influenzae type b vaccines, and inactivated influenza vaccines. Ongoing booster doses are also recommended for pneumococcal and meningococcal vaccines to maintain protection. Despite the availability of prevention tools, adherence is often a challenge. Dedicated teams or clinics focused on patient education and monitoring have demonstrated substantial improvements in vaccine coverage rates for individuals with asplenia and reduced risk of infection. Future efforts to monitor the quality of care in patients with asplenia may be important to bridge the know\u2013do gap in this high-risk population.<\/jats:p>","DOI":"10.1182\/hematology.2020000117","type":"journal-article","created":{"date-parts":[[2020,12,4]],"date-time":"2020-12-04T22:10:22Z","timestamp":1607119822000},"page":"328-335","update-policy":"https:\/\/doi.org\/10.1182\/blood.2019cm0000","source":"Crossref","is-referenced-by-count":87,"title":["Preventing infections in children and adults with asplenia"],"prefix":"10.1182","volume":"2020","author":[{"given":"Grace M.","family":"Lee","sequence":"first","affiliation":[{"name":"Division of Infectious Diseases, Department of Pediatrics, Stanford University School of Medicine, Stanford, CA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"234","reference":[{"issue":"9785","key":"2020121621163357100_B1","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1016\/S0140-6736(10)61493-6","article-title":"Post-splenectomy and hyposplenic states","volume":"378","author":"Di Sabatino","year":"2011","journal-title":"Lancet"},{"issue":"12","key":"2020121621163357100_B2","doi-asserted-by":"crossref","first-page":"3683","DOI":"10.1182\/blood.V95.12.3683","article-title":"Chronic graft versus host disease is associated with long-term risk for pneumococcal infections in recipients of bone marrow transplants","volume":"95","author":"Kulkarni","year":"2000","journal-title":"Blood"},{"key":"2020121621163357100_B3","unstructured":"Centers for Disease Control and Prevention. Data & Statistics on Sickle Cell Disease. https:\/\/www.cdc.govncbddd\/sicklecell\/data.html. Accessed 6 June 2020."},{"issue":"4","key":"2020121621163357100_B4","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1056\/NEJMcp1314291","article-title":"Clinical practice. Care of the asplenic patient","volume":"371","author":"Rubin","year":"2014","journal-title":"N Engl J Med"},{"issue":"7","key":"2020121621163357100_B5","doi-asserted-by":"crossref","first-page":"e27072","DOI":"10.1002\/pbc.27072","article-title":"Temporal trends of splenectomy in pediatric hospitalizations with immune thrombocytopenia","volume":"65","author":"Bhatt","year":"2018","journal-title":"Pediatr Blood Cancer"},{"key":"2020121621163357100_B6","unstructured":"Agency for Healthcare Research and Quality. HCUPnet: Healthcare Cost and Utilization Project. https:\/\/hcupnet.ahrq.gov. Accessed 5 June 2020."},{"issue":"1","key":"2020121621163357100_B7","doi-asserted-by":"crossref","first-page":"e2015057","DOI":"10.4084\/mjhid.2015.057","article-title":"Bacterial infections following splenectomy for malignant and nonmalignant hematologic diseases","volume":"7","author":"Leone","year":"2015","journal-title":"Mediterr J Hematol Infect Dis"},{"issue":"6","key":"2020121621163357100_B8","doi-asserted-by":"crossref","first-page":"1394","DOI":"10.1016\/j.chest.2016.03.044","article-title":"Critical illness in patients with asplenia","volume":"150","author":"O\u2019Neal","year":"2016","journal-title":"Chest"},{"issue":"1","key":"2020121621163357100_B9","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1186\/s13054-020-2769-y","article-title":"Pneumococcal purpura fulminans in asplenic or hyposplenic patients: a French multicenter exposed-unexposed retrospective cohort study","volume":"24","author":"Contou","year":"2020","journal-title":"Crit Care"},{"issue":"7","key":"2020121621163357100_B10","doi-asserted-by":"crossref","first-page":"1445","DOI":"10.1016\/j.jpedsurg.2018.06.024","article-title":"Incidence and risk factors for sepsis after childhood splenectomy","volume":"54","author":"Madenci","year":"2019","journal-title":"J Pediatr Surg"},{"issue":"3","key":"2020121621163357100_B11","doi-asserted-by":"crossref","first-page":"276.e1","DOI":"10.1016\/j.amjmed.2005.07.044","article-title":"Evaluation of severe infection and survival after splenectomy","volume":"119","author":"Kyaw","year":"2006","journal-title":"Am J Med"},{"issue":"4","key":"2020121621163357100_B12","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1016\/j.surg.2019.04.046","article-title":"Vaccination and splenectomy in Olmsted County","volume":"166","author":"Hernandez","year":"2019","journal-title":"Surgery"},{"issue":"6","key":"2020121621163357100_B13","doi-asserted-by":"crossref","first-page":"909","DOI":"10.1111\/bjh.16657","article-title":"Splenectomy in childhood for non-malignant haematologic disorders - long-term follow-up shows minimal adverse effects","volume":"190","author":"Yacobovich","year":"2020","journal-title":"Br J Haematol"},{"issue":"7","key":"2020121621163357100_B14","doi-asserted-by":"crossref","first-page":"871","DOI":"10.1093\/cid\/civ1195","article-title":"Overwhelming postsplenectomy infection: a prospective multicenter cohort study","volume":"62","author":"Theilacker","year":"2016","journal-title":"Clin Infect Dis"},{"issue":"1","key":"2020121621163357100_B15","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1016\/j.jpedsurg.2015.10.028","article-title":"Hematologic outcomes after total splenectomy and partial splenectomy for congenital hemolytic anemia","volume":"51","author":"Englum","year":"2016","journal-title":"J Pediatr Surg"},{"issue":"3","key":"2020121621163357100_B16","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1002\/ajh.23888","article-title":"Clinical outcomes of splenectomy in children: report of the splenectomy in congenital hemolytic anemia registry","volume":"90","author":"Rice","year":"2015","journal-title":"Am J Hematol"},{"key":"2020121621163357100_B17","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/j.ijid.2018.04.4319","article-title":"Fulminant septic shock caused by Capnocytophaga canimorsus in Italy: case report","volume":"72","author":"Piccinelli","year":"2018","journal-title":"Int J Infect Dis"},{"issue":"6","key":"2020121621163357100_B18","doi-asserted-by":"crossref","first-page":"1","DOI":"10.15585\/mmwr.ss6806a1","article-title":"Babesiosis surveillance \u2014 United States, 2011\u20132015","volume":"68","author":"Gray","year":"2019","journal-title":"MMWR Surveill Summ"},{"issue":"1","key":"2020121621163357100_B19","doi-asserted-by":"crossref","first-page":"53","DOI":"10.4269\/ajtmh.2004.71.53","article-title":"Report of an unusual case of persistent bacteremia by Bartonella bacilliformis in a splenectomized patient","volume":"71","author":"Henr\u00edquez","year":"2004","journal-title":"Am J Trop Med Hyg"},{"issue":"11","key":"2020121621163357100_B20","doi-asserted-by":"crossref","first-page":"861","DOI":"10.1016\/j.trstmh.2005.03.008","article-title":"Falciparum malaria after splenectomy: a prospective controlled study of 33 previously splenectomized Malawian adults","volume":"99","author":"Bach","year":"2005","journal-title":"Trans R Soc Trop Med Hyg"},{"issue":"1","key":"2020121621163357100_B21","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1093\/cid\/ciy403","article-title":"High risk of Plasmodium vivax malaria following splenectomy in Papua, Indonesia","volume":"68","author":"Kho","year":"2019","journal-title":"Clin Infect Dis"},{"issue":"8","key":"2020121621163357100_B22","doi-asserted-by":"crossref","first-page":"848","DOI":"10.1111\/imj.13348","article-title":"Spleen Australia guidelines for the prevention of sepsis in patients with asplenia and hyposplenism in Australia and New Zealand","volume":"47","author":"Kanhutu","year":"2017","journal-title":"Intern Med J"},{"issue":"6","key":"2020121621163357100_B23","doi-asserted-by":"crossref","first-page":"1583","DOI":"10.1016\/j.surg.2015.12.014","article-title":"Long-term outcomes after pediatric splenectomy","volume":"159","author":"Luoto","year":"2016","journal-title":"Surgery"},{"issue":"3","key":"2020121621163357100_B24","doi-asserted-by":"crossref","first-page":"ofaa050","DOI":"10.1093\/ofid\/ofaa050","article-title":"A single-center prospective cohort study on postsplenectomy sepsis and its prevention","volume":"7","author":"Rieg","year":"2020","journal-title":"Open Forum Infect Dis"},{"issue":"3","key":"2020121621163357100_B25","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1053\/jinf.2001.0904","article-title":"Risk of infection and death among post-splenectomy patients","volume":"43","author":"Bisharat","year":"2001","journal-title":"J Infect"},{"key":"2020121621163357100_B26","first-page":"CD003427","article-title":"Prophylactic antibiotics for preventing pneumococcal infection in children with sickle cell disease","volume":"10","author":"Rankine-Mullings","year":"2017","journal-title":"Cochrane Database Syst Rev"},{"key":"2020121621163357100_B27","author":"Kimberlin","year":"2018"},{"issue":"3","key":"2020121621163357100_B28","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1111\/j.1365-2141.2011.08843.x","article-title":"Review of guidelines for the prevention and treatment of infection in patients with an absent or dysfunctional spleen: prepared on behalf of the British Committee for Standards in Haematology by a working party of the Haemato-Oncology Task Force","volume":"155","author":"Davies","year":"2011","journal-title":"Br J Haematol"},{"issue":"35","key":"2020121621163357100_B29","doi-asserted-by":"crossref","first-page":"3594","DOI":"10.1016\/j.vaccine.2013.04.084","article-title":"Influence of initial vaccination with 13-valent pneumococcal conjugate vaccine or 23-valent pneumococcal polysaccharide vaccine on anti-pneumococcal responses following subsequent pneumococcal vaccination in adults 50 years and older","volume":"31","author":"Jackson","year":"2013","journal-title":"Vaccine"},{"issue":"4","key":"2020121621163357100_B30","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1007\/s10096-019-03485-3","article-title":"Adult vaccination for pneumococcal disease: a comparison of the national guidelines in Europe","volume":"38","author":"Bonnave","year":"2019","journal-title":"Eur J Clin Microbiol Infect Dis"},{"issue":"9","key":"2020121621163357100_B31","first-page":"258","article-title":"Licensure of a 13-valent pneumococcal conjugate vaccine (PCV13) and recommendations for use among children \u2014 Advisory Committee on Immunization Practices (ACIP), 2010","volume":"59","author":"Centers for Disease Control and Prevention (CDC)","year":"2010","journal-title":"MMWR Morb Mortal Wkly Rep"},{"issue":"32","key":"2020121621163357100_B32","doi-asserted-by":"crossref","first-page":"3779","DOI":"10.1016\/j.vaccine.2015.06.100","article-title":"Long-lasting hyporesponsivenss induced by the 23-valent pneumococcal polysaccharide vaccine (PPV23) in asplenic patients with \u03b2-thalassemia major","volume":"33","author":"Papadatou","year":"2015","journal-title":"Vaccine"},{"issue":"24","key":"2020121621163357100_B33","first-page":"527","article-title":"Use of MenACWY-CRM vaccine in children aged 2 through 23 months at increased risk for meningococcal disease: recommendations of the Advisory Committee on Immunization Practices, 2013","volume":"63","author":"MacNeil","year":"2014","journal-title":"MMWR Morb Mortal Wkly Rep"},{"issue":"22","key":"2020121621163357100_B34","first-page":"608","article-title":"Use of serogroup B meningococcal vaccines in persons aged \u226510 years at increased risk for serogroup B meningococcal disease: recommendations of the Advisory Committee on Immunization Practices, 2015","volume":"64","author":"Folaranmi","year":"2015","journal-title":"MMWR Morb Mortal Wkly Rep"},{"issue":"3","key":"2020121621163357100_B35","doi-asserted-by":"crossref","first-page":"e20174250","DOI":"10.1542\/peds.2017-4250","article-title":"Meningococcal B vaccine immunogenicity in children with defects in complement and splenic function","volume":"142","author":"Martin\u00f3n-Torres","year":"2018","journal-title":"Pediatrics"},{"issue":"4","key":"2020121621163357100_B36","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1056\/NEJMoa1900236","article-title":"Meningococcal B vaccine and meningococcal carriage in adolescents in Australia","volume":"382","author":"Marshall","year":"2020","journal-title":"N Engl J Med"},{"key":"2020121621163357100_B37","unstructured":"Centers for Disease Control and Prevention. Immunization Schedules: Table 3. Recommended Child and Adolescent Immunization Schedule by Medical Indication, United States, 2020. https:\/\/www.cdc.gov\/vaccines\/schedules\/hcp\/imz\/child-indications.html. Accessed 13 June 2020."},{"key":"2020121621163357100_B38","unstructured":"Centers for Disease Control and Prevention. Immunization Schedules: Table 2. Recommended Adult Immunization Schedule by Medical Condition and Other Indications, United States, 2020. https:\/\/www.cdc.gov\/vaccines\/schedules\/hcp\/imz\/adult-conditions.html. Accessed 13 June 2020."},{"key":"2020121621163357100_B39","unstructured":"Centers for Disease Control and Prevention. Influenza (Flu): Prevention and Control of Seasonal Influenza with Vaccines, 2019-20. https:\/\/www.cdc.gov\/flu\/professionals\/acip\/index.htm. Accessed 13 June 2020."},{"issue":"1","key":"2020121621163357100_B40","first-page":"39","article-title":"Immunization adherence in children with sickle cell disease: a single-institution experience","volume":"25","author":"Infanti","year":"2020","journal-title":"J Pediatr Pharmacol Ther"},{"issue":"14","key":"2020121621163357100_B41","doi-asserted-by":"crossref","first-page":"1688","DOI":"10.1016\/j.vaccine.2015.02.026","article-title":"Vaccination status and immune response to 13-valent pneumococcal conjugate vaccine in asplenic individuals","volume":"33","author":"Nived","year":"2015","journal-title":"Vaccine"},{"issue":"7","key":"2020121621163357100_B42","doi-asserted-by":"crossref","first-page":"865","DOI":"10.1002\/pbc.21961","article-title":"Compliance with immunizations in splenectomized individuals with hereditary spherocytosis","volume":"52","author":"Grace","year":"2009","journal-title":"Pediatr Blood Cancer"},{"issue":"3","key":"2020121621163357100_B43","doi-asserted-by":"crossref","first-page":"E72","DOI":"10.1002\/ajh.25710","article-title":"Adherence to infectious disease screening and immunization guidelines when treating non-malignant immune-mediated hematologic disorders","volume":"95","author":"Malpica-Castillo","year":"2020","journal-title":"Am J Hematol"},{"issue":"3","key":"2020121621163357100_B44","doi-asserted-by":"crossref","first-page":"e17302","DOI":"10.1371\/journal.pone.0017302","article-title":"Physicians report barriers to deliver best practice care for asplenic patients: a cross-sectional survey","volume":"6","author":"Lammers","year":"2011","journal-title":"PLoS One"},{"issue":"9","key":"2020121621163357100_B45","doi-asserted-by":"crossref","first-page":"538","DOI":"10.5694\/mja13.10630","article-title":"Adherence to infection prevention measures in a statewide spleen registry","volume":"200","author":"Wang","year":"2014","journal-title":"Med J Aust"},{"issue":"7","key":"2020121621163357100_B46","doi-asserted-by":"crossref","first-page":"856","DOI":"10.1016\/j.amjmed.2017.01.024","article-title":"Splenectomy as a destination: improving quality of care among asplenic veterans through a travel clinic","volume":"130","author":"Mitchell","year":"2017","journal-title":"Am J Med"},{"issue":"7821","key":"2020121621163357100_B47","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1038\/s41586-020-2521-4","article-title":"Factors associated with COVID-19-related death using OpenSAFELY","volume":"584","author":"Williamson","year":"2020","journal-title":"Nature"},{"issue":"2","key":"2020121621163357100_B48","doi-asserted-by":"crossref","first-page":"e57","DOI":"10.1111\/bjh.16779","article-title":"COVID-19 infection and sickle cell disease: a UK centre experience","volume":"190","author":"McCloskey","year":"2020","journal-title":"Br J Haematol"},{"issue":"40","key":"2020121621163357100_B49","first-page":"816","article-title":"Use of 13-valent pneumococcal conjugate vaccine and 23-valent pneumococcal polysaccharide vaccine for adults with immunocompromising conditions: recommendations of the Advisory Committee on Immunization Practices (ACIP)","volume":"61","author":"Centers for Disease Control and Prevention (CDC)","year":"2012","journal-title":"MMWR Morb Mortal Wkly Rep"},{"issue":"25","key":"2020121621163357100_B50","first-page":"521","article-title":"Use of 13-valent pneumococcal conjugate vaccine and 23-valent pneumococcal polysaccharide vaccine among children aged 6-18 years with immunocompromising conditions: recommendations of the Advisory Committee on Immunization Practices (ACIP)","volume":"62","author":"Centers for Disease Control and Prevention (CDC)","year":"2013","journal-title":"MMWR Morb Mortal Wkly Rep"},{"issue":"19","key":"2020121621163357100_B51","doi-asserted-by":"crossref","first-page":"509","DOI":"10.15585\/mmwr.mm6619a6","article-title":"Updated recommendations for use of MenB-FHbp serogroup B meningococcal vaccine \u2014 Advisory Committee on Immunization Practices, 2016","volume":"66","author":"Patton","year":"2017","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"2020121621163357100_B52","unstructured":"Centers for Disease Control and Prevention. Vaccine Information for Adults: Asplenia and Adult Vaccination. https:\/\/www.cdc.gov\/vaccines\/adults\/rec-vac\/health-conditions\/asplenia.html. Accessed 21 October 2020."}],"container-title":["Hematology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/ashpublications.org\/hematology\/article-pdf\/2020\/1\/328\/1794847\/hem2020000117c.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"http:\/\/ashpublications.org\/hematology\/article-pdf\/2020\/1\/328\/1794847\/hem2020000117c.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,12,18]],"date-time":"2020-12-18T13:12:21Z","timestamp":1608297141000},"score":1,"resource":{"primary":{"URL":"https:\/\/ashpublications.org\/hematology\/article\/2020\/1\/328\/474295\/Preventing-infections-in-children-and-adults-with"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,12,4]]},"references-count":52,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2020,12,4]]}},"URL":"https:\/\/doi.org\/10.1182\/hematology.2020000117","relation":{},"ISSN":["1520-4391","1520-4383"],"issn-type":[{"value":"1520-4391","type":"print"},{"value":"1520-4383","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,12,4]]}}}